Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine-XR for Depression and Cardiovascular Risk
NCT00951483Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Jul 2009
- Primary completion
- Oct 2011
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in major depressive disorder (MDD), generalized anxiety disorder (GAD), sponsored by Loyola University Chicago. Started Jul 2009; status: completed.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00951483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00951483.